Are rs12785878 GT and rs2282679 GT associated with lower vitamin D status?

Genetic variation in the DHCR7/NADSYN1 and GC genes plays a critical role in determining an individual's systemic vitamin D status.

Mechanistic pathways of synthesis and transport

• Impaired synthesis (rs12785878): The rs12785878 variant is located near the DHCR7/NADSYN1 gene. DHCR7 encodes 7-dehydrocholesterol reductase, which converts 7-dehydrocholesterol (7-DHC) to cholesterol. This enzyme directly competes with the UVB-driven conversion of 7-DHC to vitamin D3 in the skin. The heterozygous GT genotype represents an intermediate state that limits 7-DHC precursor availability, modestly decreasing cutaneous synthesis efficiency compared to the TT genotype.
• Altered transport (rs2282679): The rs2282679 variant resides within the GC gene, which encodes vitamin D-binding protein (DBP), the primary carrier of circulating vitamin D. The heterozygous GT genotype alters DBP concentration and binding affinity, which disrupts the transport kinetics and distribution of circulating 25-hydroxyvitamin D [25(OH)D].

Impact on systemic vitamin D status

• Reduced circulating levels: Together, impaired cutaneous synthesis and altered transport kinetics lower overall circulating 25(OH)D status. Reduced precursor synthesis limits the systemic pool, while compromised DBP transport impairs the retention and stabilization of the metabolite in circulation.

Bottom line

• The heterozygous GT genotypes at rs12785878 and rs2282679 are robustly associated with lower vitamin D status. This occurs through distinct but complementary mechanisms: rs12785878 limits cutaneous vitamin D synthesis via the DHCR7 pathway, while rs2282679 impairs transport by altering vitamin D binding protein functionality.